Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 USD | +0.46% | +19.49% | +47.09% |
20/06 | Ocular Therapeutix Shares Rise After TD Cowen Upgrades Rating, Increases Price Target | MT |
20/06 | TD Cowen Upgrades Ocular Therapeutix to Buy From Hold, Adjusts Price Target to $11 From $7 | MT |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bioresorbable Hydrogel Platform Technology
99.0
%
| 50 | 98.0 % | 58 | 99.0 % | +14.69% |
Collaboration
1.0
%
| 1 | 2.0 % | 1 | 1.0 % | -44.74% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 51 | 100.0 % | 58 | 100.0 % | +13.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 25/17/25 |
Chief Tech/Sci/R&D Officer | - | 28/21/28 | |
Jeffrey S. Heier
CTO | Chief Tech/Sci/R&D Officer | 63 | 11/15/11 |
Peter Jarrett
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/01 |
Scott Corning
IRO | Public Communications Contact | - | 01/10/01 |
Tracy Smith
HRO | Human Resources Officer | - | 01/20/01 |
Peter K. Kaiser
PRN | Corporate Officer/Principal | - | 22/02 |
General Counsel | 64 | 25/20/25 | |
Corporate Officer/Principal | 62 | 11/19/11 | |
Pauline Jen Ryan
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 10/23/10 |
Director/Board Member | 76 | 05/12/05 | |
Merilee Raines
BRD | Director/Board Member | 68 | 20/21/20 |
Charles Warden
BRD | Director/Board Member | 55 | 01/08/01 |
Leslie Williams
BRD | Director/Board Member | 64 | 20/19/20 |
Jeffrey S. Heier
CTO | Chief Tech/Sci/R&D Officer | 63 | 11/15/11 |
Pravin Dugel
CEO | Chief Executive Officer | 60 | 21/02 |
Seung Suh Hong
BRD | Director/Board Member | 66 | 11/19/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 154,888,915 | 153,675,002 ( 99.22 %) | 0 | 99.22 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.09% | 101.61Cr | |
+55.19% | 81TCr | |
+47.26% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+18.40% | 25TCr | |
+3.64% | 23TCr | |
+12.98% | 22TCr | |
+10.86% | 17TCr | |
-2.78% | 16TCr |
- Stock Market
- Equities
- OCUL Stock
- Company Ocular Therapeutix, Inc.